Submitted for Publication: October 11, 2011; final revision received February 14, 2012; accepted March 30, 2012.
Published Online: November 26, 2012. doi:10.1001/jamapsychiatry.2013.265
MRC AIMS Consortium Members: Anthony J. Bailey, MD, PhD, Simon Baron-Cohen, BA, PhD, FBPsC, MPhil, Patrick F. Bolton, PhD, FRCPsych, Edward T. Bullmore, MD, PhD, FRCPsych, FMedSci, Sarah Carrington, PhD, Bishmadev Chakrabarti, PhD, Eileen Daly, BA, Sean C. Deoni, PhD, Christine Ecker, BSc, MSc, PhD, Francesca Happe, PhD, Julian Henty, PhD, Peter Jezzard, PhD, Patrick Johnston, BSc, PhD, Derek K. Jones, PhD, Meng-Chuan Lai, MD, PhD, Michael V. Lombardo, BA, PhD, Anya Madden, BSc, Diane Mullins, MD, Clodagh M. Murphy, FRCPsych, Declan G. M. Murphy, MBBS, FRCPsych, MD, Greg Pasco, PhD, Susan Sadek, MD, Debbie Spain, BSc, Rose Steward, BSc, John Suckling, PhD, Sally Wheelwright, BSc, and Steven C. Williams, BSc, PhD.
Conflict of Interest Disclosures: Dr Bullmore is employed half time by GlaxoSmithKline and holds shares in GlaxoSmithKline.
Funding/Support: The MRC AIMS Consortium is a collaboration of autism research centers in the United Kingdom including the Institute of Psychiatry, King's College London; the Autism Research Centre, University of Cambridge; and the Autism Research Group, University of Oxford. It is funded by the Medical Research Council and headed by the Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry. This work was supported by the AIMS Consortium through grant G0400061 from the Medical Research Council and by the NIHR Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry, and South London & Maudsley NHS Foundation Trust. Scanning took place in 3 centers (London, Oxford, and Cambridge; local principal investigators were Drs Bailey, Baron-Cohen, Bullmore, and D. G. M. Murphy).
Additional Contributions: We are grateful to those who agreed to be scanned and who gave their time so generously to this study.